Startup and Venture Investment News — Tuesday, 22 September 2026: Nscale Goes Public with a $35 Billion Target, Holtec Delays Listing, Market Evaluates "AI Pause"

Key points for venture investors:

• Nscale has filed for an IPO on the NYSE; valuation target—up to $35 billion.
• Holtec Nuclear has postponed its offering of up to $900 million due to market conditions.
• OpenAI has pushed its IPO to 2027; investors are proposing a round at a valuation of $1.2 trillion; Anthropic remains on track for a Nasdaq listing.
• Emulate is preparing a seed round of up to $700 million, while Euclyd has raised €200 million in a Series A round.
• Crux AI is securing a $22 billion loan backed by chips, and Bloom Energy is set for $25 billion in project financing.
• The Indian deeptech investment alliance has committed to investing $3 billion, and CATL is launching a venture fund of $860 million.

Nscale: A Crucial IPO Test for AI Infrastructure

The UK-based neo-cloud provider Nscale submitted its prospectus to the SEC on Friday and intends to trade on the NYSE under the ticker NSCL. The underwriters are Goldman Sachs, J.P. Morgan, and Morgan Stanley. Revenue for the first half of 2026 rose to $140.6 million versus $10.4 million a year earlier, while net losses expanded to $1.02 billion. Remaining contract obligations reach $56.4 billion; however, over half of the revenue is derived from a single client. According to media reports, the company aims to raise up to $3 billion at a valuation of up to $35 billion—compared to $14.6 billion in the March Series C round. Concurrently, Nscale has arranged a convertible loan from Nvidia.

For venture funds, this is the first autumn indicator of how public investors will assess a capital-intensive model with contracted demand, high client concentration, and reliance on a single GPU supplier.

Holtec and the IPO Window: Selectivity Over Euphoria

Holtec Nuclear, once regarded as the standout IPO of September, has postponed its offering. The backdrop is unfavourable: X-energy trades about 37% below its April listing price, while Standard Nuclear is down 21%. The IPO window has not closed, but it has narrowed:

• This week, Bamboo Insurance ($665 million at a valuation of $3.3 billion) and defence materials manufacturer Amaero ($53 million) are expected;
• Revolut is considering a dual listing in New York and London, targeting a valuation of up to $200 billion.

“AI Pause” and Fed Rate: A Dual Filter for Valuations

Anthropic CEO Dario Amodei published an essay urging a coordinated slowdown in advancing model capabilities. He has garnered support from Sam Altman and leaders from other major tech firms. Anthropic is introducing independent safety auditors. The market reacted with a sell-off in semiconductors, but by the end of the week, the Nasdaq added 0.7%, while the Dow lost 1.7%.

Industry analysts highlight the implications for venture investments: longer model release cycles, potential shifts in data centre commitments, extended exit timelines, and additional pressure on LPs. Competition is shifting from "raw" performance to distribution, reliability, and cost—favouring larger players. Concurrently, there are suggestions to regulate owners of more than 5% of computing power, akin to systemically important banks.

OpenAI and Anthropic: Trillion-Dollar Valuations, Divergent Paths

Investors have proposed a round for OpenAI at a valuation of around $1.2 trillion—41% higher than March's $852 billion, when the company raised $122 billion. There are reportedly no formal negotiations; some proposals involve stock sales by employees. Annual revenue has exceeded $40 billion, with an IPO anticipated in 2027. Anthropic, valued at $965 billion in May, is still preparing for a marketing push for its Nasdaq listing in mid-October. Its listing will set the public multiplier for the entire AI sector.

Mega-Rounds and New Unicorns: Capital Concentrates

• Temporal — $550 million Series E at a valuation of $12.55 billion; platform for AI agents.
• Fab2 — $500 million Series A for mass-producing compact chip factories.
• Suniva — $835 million in debt and equity for the production of solar cells in the US.
• Ridgeline — $250 million at a valuation of $1.45 billion; Cornelis Networks — $205 million for AI networking solutions.
• Penelope Health — $100 million for automating administrative processes for physicians.

A week earlier, Cognition raised $2 billion at a valuation of $48 billion, while the Boring Company secured $3 billion at $23 billion. Median rounds A and B remain modest: the gap between category leaders and other startups is widening.

Debt Instead of Equity: Chips and Energy as Collateral

Funding for AI infrastructure is increasingly moving to the credit market. A consortium of ten banks is providing $22 billion secured by TPU and client contracts for Crux AI—a cloud project by Blackstone and Alphabet with $5 billion in equity. Bloom Energy has reached an agreement with Brookfield for $25 billion in project financing for data centre energy supply. Nvidia is investing $2 billion in Brookfield's $10 billion AI infrastructure fund. For venture funds, this means less dilution of stakes in portfolio companies but increased sensitivity to interest rates.

M&A: Signed Does Not Mean Closed

Deals remain a second channel for liquidity; however, closing timelines are extending. The acquisition of Hugging Face by Nvidia for $12.9 billion is expected to close only in the first half of 2027. Other signed but not yet completed deals include Visa—BioCatch ($2.4 billion), Analog Devices—Alif Semiconductor ($1.35 billion), Bending Spoons—Miro ($1.36 billion), and Dynatrace—Arize AI ($915 million). SoftBank has agreed to acquire the Robotics and AI Institute, which is currently undergoing regulatory review in the US. SPACs are making a comeback: nuclear technology developer HGP is merging with Meshflow at a valuation of $1.2 billion.

Europe, Asia, and Emerging Markets

• United Kingdom: Emulate, founded in August by former Google DeepMind staff, is discussing a seed round of up to $700 million at a valuation of around $3.7 billion; leading investors include Index Ventures and Lightspeed. ElevenLabs is preparing a Series E of over $500 million, possibly involving the Scaleup Europe Fund.
• Netherlands: Euclyd raised €200 million in Series A for inference chips; among the round's leaders is Samsung.
• India: India Deep Tech Alliance has committed to invest $3 billion, with $250 million deployed in the first year.
• China: CATL is creating a venture fund of $860 million for AI and robotics; its robotaxi division, Hello, has raised around $100 million.
• Latin America: Brazilian VOLL has secured $140 million from Warburg Pincus.

What This Means for Venture Investors and Funds

1. Exits are shifting. The delay of OpenAI's IPO and Holtec's pause extend the liquidity horizon—DPI planning needs revisiting.
2. Nscale and Anthropic will set multipliers. Their acceptance by the public market will determine late-stage valuations for 2027.
3. Regulatory risk has become an investment factor. Safety audits and potential computing restrictions must be factored into due diligence.
4. The capital structure is changing. Debt secured by chips and contracts reduces dilution but requires a robust unit economics at a 4% interest rate.
5. The team premium has reached its limit. Seed rounds in the hundreds of millions without a product raise the bar for the next round and the risk of down-rounds.

The venture market remains liquid, but it pays for proven demand, control over scarce resources, and capital discipline. These criteria will define news from startups and venture investments until the end of the third quarter.